{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-23-000129","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.892312+00:00","generated_at":"2026-06-09T00:29:46.479153+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Health Catalyst beats Q3 guidance; raises FY2023 revenue outlook; Adj. EBITDA positive","bullets":["Q3 total revenue $73.8M (+8% YoY), above guidance midpoint; net loss $22.0M vs $45.7M loss in Q3 2022.","Adjusted EBITDA $2.0M (improvement from -$4.6M YoY), also above guidance midpoint of $1.25M.","Raised FY2023 revenue guidance to $291M-$296M from $290.5M-$295.5M; reiterated Adj. EBITDA $10M-$12M.","New DOS client: Accountable Health Partners (~400k patients); Q4 expected to be a large bookings quarter.","Mid-term targets: revenue reacceleration in 2024, 10% Adj. EBITDA margin in 2025, long-term 20%+ growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-23-000129","json":"https://secwatch.observer/filing/0001636422-23-000129.json","markdown":"https://secwatch.observer/filing/0001636422-23-000129.md","text":"https://secwatch.observer/filing/0001636422-23-000129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/0001636422-23-000129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/hcat-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:29:46.479153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb578e4ae56095955c49ed4c5a0f567f962f97cf","claim":"Health Catalyst, Inc. reported the quarter ended September 30, 2023 results: revenue $73.8 million, net income $(22,032) thousand. Guidance raised.","evidence_excerpt":"reported financial results for the quarter ended September 30, 2023. “For the third quarter of 2023, I am pleased by our strong financial results, including total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, with these results beating the mid-point of our quarterly guidance on each metric. Additionally, we are grateful to be in a position to raise","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/0001636422-23-000129-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$73.8 million"},{"label":"Net income","value":"$(22,032) thousand"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}